RETRACTED ARTICLE: Effects of Dapagliflozin on myocardial remodeling, inflammatory factors, and cardiac events in heart failure with preserved ejection fraction.

Song B, Zhang H, Zhou B.

Open source

DOI
10.1007/s00210-023-02590-7
Published
2023-06-27
Container
Naunyn Schmiedebergs Arch Pharmacol
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-023-02590-7,
  title = {RETRACTED ARTICLE: Effects of Dapagliflozin on myocardial remodeling, inflammatory factors, and cardiac events in heart failure with preserved ejection fraction.},
  author = {Song B and  Zhang H and  Zhou B.},
  year = {2024},
  journal = {Naunyn Schmiedebergs Arch Pharmacol},
  doi = {10.1007/s00210-023-02590-7},
  url = {https://doi.org/10.1007/s00210-023-02590-7}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: Effects of Dapagliflozin on myocardial remodeling, inflammatory factors, and cardiac events in heart failure with preserved ejection fraction.
AU  - Song B
AU  -  Zhang H
AU  -  Zhou B.
PY  - 2024
JO  - Naunyn Schmiedebergs Arch Pharmacol
DO  - 10.1007/s00210-023-02590-7
UR  - https://doi.org/10.1007/s00210-023-02590-7
ER  - 

APA

B, S., H, Z., & B., Z. (2024). RETRACTED ARTICLE: Effects of Dapagliflozin on myocardial remodeling, inflammatory factors, and cardiac events in heart failure with preserved ejection fraction.. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-023-02590-7

Source records